XML 9 R3.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ 15,825 $ 14,013 $ 51,330 $ 43,464
Selling, general and administrative 18,618 17,786 60,086 56,558
Total operating expenses 34,443 31,799 111,416 100,022
Income (loss) from operations 1,236 (961) (8,040) (12,776)
Non-operating expense, net:        
Foreign exchange loss (28) (241) (1,226) (173)
Interest expense (2,119) (2,260) (6,379) (6,824)
Other income, net 976 604 2,427 1,468
Total non-operating expense, net (1,171) (1,897) (5,178) (5,529)
Income (loss) before income taxes 65 (2,858) (13,218) (18,305)
Provision for income taxes 85 76 235 94
Net loss (20) (2,934) (13,453) (18,399)
Net loss attributable to noncontrolling interest (1) 0 (10) (2)
Net loss attributable to Cerus Corporation $ (19) $ (2,934) $ (13,443) $ (18,397)
Net loss per share attributable to Cerus Corporation        
Basic $ (0) $ (0.02) $ (0.07) $ (0.1)
Diluted $ (0) $ (0.02) $ (0.07) $ (0.1)
Weighted average shares outstanding:        
Basic 191,830 185,424 190,083 184,170
Diluted 191,830 185,424 190,083 184,170
Product        
Revenue $ 52,698 $ 46,017 $ 148,382 $ 129,461
Cost of revenue 24,558 19,818 65,843 57,324
Gross profit 28,140 26,199 82,539 72,137
Government Contract        
Revenue $ 7,539 $ 4,639 $ 20,837 $ 15,109